Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01335542 · ClinicalTrials.gov registry record · Phase 4
Analgesia After Total Knee Arthroplasty: Peri-Articular Injection Versus Epidural + Femoral Nerve Blockade
A Phase 4 study, sponsored by Hospital for Special Surgery, New York.
- Completed
- Registry status
- Phase 4
- Development phase
- 91
- Enrollment target
NCT01335542 is a Phase 4 study that has completed, run by Hospital for Special Surgery, New York. The registered enrollment target is 91 participants.
The verdict
NCT01335542, a Phase 4 study, has completed, sponsored by Hospital for Special Surgery, New York.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 91 participants
- Enrollment target
Study Summary
There are 2 common ways to manage pain after total knee arthroplasty at our institution. Some patients receive an epidural analgesia, a femoral nerve block and pills for pain. More recently, some surgeons have replaced femoral nerve blockade with peri-articular injections. These patients receive a peri-articular injection (injection of pain medication around the knee), pills for pain and a pain patch on the skin. The purpose of this research project is to find out if one of these ways to treat pain is better than the other. The investigators will look at this question in many ways, but the main way is how long it takes for you to be judged ready for discharge from the hospital.
Interventions
- PROCEDURE Peri-Articular Injection
- PROCEDURE Epidural Pathway (PCEA+FNB)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 91 participants |
| Start Date | 2010-03 |
| Est. Completion | 2011-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01335542
The ClinicalTrials.gov registry entry for NCT01335542 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 91 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hospital for Special Surgery, New York, which has 194 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Peri-Articular Injection is the first listed.
NCT01335542 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01335542 about?
NCT01335542 is a clinical study titled "Analgesia After Total Knee Arthroplasty: Peri-Articular Injection Versus Epidural + Femoral Nerve Blockade". There are 2 common ways to manage pain after total knee arthroplasty at our institution. Some patients receive an epidural analgesia, a femoral nerve block and pills for pain. More recently, some surgeons have replaced femoral nerve blockade with peri-articular injections. These patients receive a p...
What is the current status of trial NCT01335542?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 91 participants. The study started on 2010-03. Estimated completion is 2011-09.
What interventions are being tested in trial NCT01335542?
The interventions under investigation include: Peri-Articular Injection (PROCEDURE), Epidural Pathway (PCEA+FNB) (PROCEDURE).
Who is sponsoring clinical trial NCT01335542?
This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.